NCT01910025 - PH 2 ADI-PEG 20 Study in Non-Hodgkin's Lymphoma Subjects Who Have Failed Prior Systemic Therapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 6, 2013

Primary Completion Date

August 31, 2016

Study Completion Date

December 15, 2017

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG

ADI-PEG 20

Trial Locations (5)

Chang Gung Medical Foundation-Kaohsiung, Kaohsiung City

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

CMUH, Taichung

National Cheng Kung University Hospital(NCKUH), Tainan City

CGMH-LK, Taoyuan District